Protalix BioTherapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $92.2M | $82.2M | $63.3M |
| FY2017 | $101.7M | $72.2M | $51.2M |
| FY2018 | $114.0M | $61.1M | $37.8M |
| FY2019 | $115.7M | $45.4M | $17.8M |
| FY2020 | $95.0M | $67.9M | $18.3M |